The Exchange has announced the addition of Standard Life and Royal Liver to its Pension Term Assurance (PTA) service.
Joining Liverpool Victoria, Friends Provident, Scottish Equitable and Legal & General, the Exchange says Standard Life and Royal Liver will be able to use the new service to build on the existing quotes and e-submission systems already offered on the Exweb portal.
One of the new additions to the service will be Royal Liver’s “Pension Life Cover”, which claims to be the first post A-Day PTA product to offer both online underwriting and in-depth telephone underwriting on all applications.
The Exchange says although the two latest additions brings the number of product providers on its new service up to six, it is expecting a further four providers to join the platform over the next couple of months.
Andy Milburn, IFA market manager at Royal Liver, says through the new service, advisers can place business based on risk in minutes, using straight through processing within the Exweb environment just by clicking on the ‘buy’ button.
He adds Royal Liver are looking forward to working closely with the Exchange to help advisers to benefit from the new service.
And Peter Brutin, sales technology manager at Standard Life, says the company is delighted to have launched its “life assurance with tax relief” product on Exweb as its first portal offering.
Meanwhile, David Child, managing director of The Exchange, says: “The addition of Standard Life and Royal Liver to our Exweb PTA service is another example of The Exchange’s commitment to providing comprehensive, market leading services, helping advisers select the best products in the market.”
If you have any comments you would like to add to this story or would like to speak to its author about a similar subject, telephone Nyree Stewart on 020 7968 4558 or email [email protected]IFAonline
Partner Insight: Cathi Harrison, director of para-sols and Apricity and Clare Farrell managing director at Northfield Wealth met in London recently to discuss how to stay on top of regulatory risk.
CEO labels whistle-blower as 'brave'
Adds up to £130m FUM
Our weekly heads-up for advisers
Think tank report